SureTrader Nadex Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Charles River Laboratories International, Inc. (CRL)

CRL RSS Feed
Add CRL Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 1/4/2017 9:44:00 AM - Followers: 1 - Board type: Free - Posts Today: 0

Charles River Laboratories International, Inc. 251 Ballardvale Street Wilmington, MA 01887 United States - Map Phone: 781-222-6000 Fax: 978-988-9236 Website: http://www.criver.com Details Index Membership: S&P 400 MidCap S&P 1500 Super Comp Sector: Healthcare Industry: Biotechnology Full Time Employees: 8,000 Business Summary Charles River Laboratories International, Inc. provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts. The company offers a portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Its portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing customized approaches to support both single-study or broad-based programs. Charles River Laboratories International serves pharmaceutical and biotechnology companies, as well as government agencies, hospitals, and academic institutions. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CRL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CRL News: Charles River Laboratories Schedules First-Quarter 2017 Earnings Release and Conference Call 04/12/2017 04:30:00 PM
CRL News: Nimbus Therapeutics Enters into Strategic Partnership with Charles River Laboratories to Advance New Therapeutic Programs 04/05/2017 08:00:00 AM
CRL News: Charles River Laboratories Announces Launch of Triple-Immunodeficient Mouse Model for Oncology Research 04/03/2017 08:00:00 AM
CRL News: Proxy Statement (definitive) (def 14a) 03/30/2017 09:41:40 AM
CRL News: Statement of Changes in Beneficial Ownership (4) 03/17/2017 07:12:29 AM